UCLA Vine Street Clinic

Phase I Safety-Interaction Study of Mirtazapine for the Treatment of Methamphetamine Use Disorder
Phase I Safety-Interaction Study of Mirtazapine for the Treatment of Methamphetamine Use Disorder
Moderna’s mRNA-1273 vaccine, The COVE Study
Moderna’s mRNA-1273 vaccine, The COVE Study
FREE CONDOMS
FREE CONDOMS
HPTN 083: A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis (PrEP) in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men
HPTN 083: A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis (PrEP) in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE), better known as the M Study
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE), better known as the M Study

About

CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.

 Site by Pendari / admin login